TrialCirculation2013

Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Richard G Bach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.